Follow
Oguzhan Alagoz
Title
Cited by
Cited by
Year
State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3
U Siebert, O Alagoz, AM Bayoumi, B Jahn, DK Owens, DJ Cohen, ...
Medical Decision Making 32 (5), 690-700, 2012
7712012
Markov decision processes: a tool for sequential decision making under uncertainty
O Alagoz, H Hsu, AJ Schaefer, MS Roberts
Medical Decision Making 30 (4), 474-483, 2010
3302010
Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012
SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ...
Jama 319 (2), 154-164, 2018
2952018
The optimal timing of living-donor liver transplantation
O Alagoz, LM Maillart, AJ Schaefer, MS Roberts
Management Science 50 (10), 1420-1430, 2004
2932004
Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies
JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ...
Annals of internal medicine 164 (4), 215-225, 2016
2912016
Modeling secrecy and deception in a multiple-period attacker–defender signaling game
J Zhuang, VM Bier, O Alagoz
European Journal of Operational Research 203 (2), 409-418, 2010
2722010
OR Forum—A POMDP approach to personalize mammography screening decisions
T Ayer, O Alagoz, NK Stout
Operations research 60 (5), 1019-1034, 2012
2492012
Comparison of logistic regression and artificial neural network models in breast cancer risk estimation
T Ayer, J Chhatwal, O Alagoz, CE Kahn Jr, RW Woods, ES Burnside
Radiographics 30 (1), 13-22, 2010
2342010
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts
BL Sprague, NK Stout, C Schechter, NT Van Ravesteyn, M Cevik, ...
Annals of internal medicine 162 (3), 157-166, 2015
2332015
Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration
T Ayer, O Alagoz, J Chhatwal, JW Shavlik, CE Kahn Jr, ES Burnside
Cancer 116 (14), 3310-3321, 2010
2032010
Determining the acceptance of cadaveric livers using an implicit model of the waiting list
O Alagoz, LM Maillart, AJ Schaefer, MS Roberts
Operations Research 55 (1), 24-36, 2007
1812007
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality
D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ...
Journal of the National Cancer Institute 106 (11), dju289, 2014
1742014
Optimal breast biopsy decision-making based on mammographic features and demographic factors
J Chhatwal, O Alagoz, ES Burnside
Operations research 58 (6), 1577-1591, 2010
1582010
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
NK Stout, SJ Lee, CB Schechter, K Kerlikowske, O Alagoz, D Berry, ...
Journal of the National Cancer Institute 106 (6), dju092, 2014
1572014
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk
NT Van Ravesteyn, DL Miglioretti, NK Stout, SJ Lee, CB Schechter, ...
Annals of internal medicine 156 (9), 609-617, 2012
1552012
A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process
SM Shechter, CL Bryce, O Alagoz, JE Kreke, JE Stahl, AJ Schaefer, ...
Medical Decision Making 25 (2), 199-209, 2005
1472005
A survey of optimization models on cancer chemotherapy treatment planning
J Shi, O Alagoz, FS Erenay, Q Su
Annals of Operations Research 221, 331-356, 2014
1312014
Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts
CI Lee, M Cevik, O Alagoz, BL Sprague, ANA Tosteson, DL Miglioretti, ...
Radiology 274 (3), 772-780, 2015
1272015
Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes
A Trentham-Dietz, K Kerlikowske, NK Stout, DL Miglioretti, CB Schechter, ...
Annals of internal medicine 165 (10), 700-712, 2016
1232016
Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling
O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ...
JNCI: Journal of the National Cancer Institute 113 (11), 1484-1494, 2021
1222021
The system can't perform the operation now. Try again later.
Articles 1–20